South Korea Migraine Treatment Market to 2032
Overview
The South Korea Migraine Treatment Market is expected to reach a 404.06 USD Billion by 2032 and is projected to grow at a CAGR of 24.99% from 2025 to 2032.
Revenue, 2024 (USD Billion)
139.80
Forecast, 2032 (USD Billion)
404.06
CAGR, 2024 - 2032
24.99%
Report Coverage
South Korea
South Korea Migraine Treatment Market 2018-2032 USD Billion
South Korea Migraine Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 139.80 USD Billion
- Projected Market Size (2032): 404.06 USD Billion
- CAGR (2025-2032): 24.99%
Key Findings of South Korea Migraine Treatment Market
- The South Korea Migraine Treatment Market was valued at 139.80 USD Billion in 2024.
- The South Korea Migraine Treatment Market is likely to grow at a CAGR of 24.99% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Oral in Route of Administration Segment accounted for the largest share of the market with a revenue of 109.42 USD Billion
- The fastest growing segment Preventive/ Prophylactic Treatment in Treatment Segment grew Fastest with a CAGR of 31.05% during the forecast period from 2024 to 2032.
South Korea Migraine Treatment Market Scope
South Korea Migraine Treatment Market Segmentation & Scope
Treatment
- Devices
- Non-Pharmacological Therapies
- Preventive/ Prophylactic Treatment
- Acute / Abortive Treatment
Types of Migraine
- Others
- Chronic
- Migraine with Aura
- Episodic
Product Type
- Over The Counter
- Prescription
Route of Administration
- Others
- Nasal Sprays
- Parenteral
- Oral
Type
- Branded
- Generic
End User
- Others
- Homecare
- Clinics
- Hospitals
Distribution Channel
- Others
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
South Korea Migraine Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2019 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 139.80 USD Billion |
| Market Value in 2032 | 404.06 USD Billion |
| CAGR (2025-2032) | 24.99% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment,Types of Migraine,Product Type,Route of Administration,Type,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 139.80 USD Billion in 2024
- Key Country: South Korea, leading in terms of revenue with value of 139.80 USD Billion in 2024.
Segments and Scope
-
South Korea Migraine Treatment Market to 2032, By Treatment
- Acute / Abortive Treatment is the largest segment in South Korea Migraine Treatment Market to 2032 with a revenue of 66.71 USD Billion in the year 2024.
- Preventive/ Prophylactic Treatment is the Fastest growing segment in South Korea Migraine Treatment Market to 2032 with a Growth rate of 19.88 % in forecast period 2025-2032.
-
South Korea Migraine Treatment Market to 2032, By Types of Migraine
- Episodic is the largest segment in South Korea Migraine Treatment Market to 2032 with a revenue of 84.42 USD Billion in the year 2024.
- Episodic is the Fastest growing segment in South Korea Migraine Treatment Market to 2032 with a Growth rate of 27.21 % in forecast period 2025-2032.
-
South Korea Migraine Treatment Market to 2032, By Product Type
- Prescription is the largest segment in South Korea Migraine Treatment Market to 2032 with a revenue of 108.68 USD Billion in the year 2024.
- Prescription is the Fastest growing segment in South Korea Migraine Treatment Market to 2032 with a Growth rate of 26.10 % in forecast period 2025-2032.
-
South Korea Migraine Treatment Market to 2032, By Route of Administration
- Oral is the largest segment in South Korea Migraine Treatment Market to 2032 with a revenue of 109.42 USD Billion in the year 2024.
- Oral is the Fastest growing segment in South Korea Migraine Treatment Market to 2032 with a Growth rate of 25.39 % in forecast period 2025-2032.
-
South Korea Migraine Treatment Market to 2032, By Type
- Generic is the largest segment in South Korea Migraine Treatment Market to 2032 with a revenue of 109.39 USD Billion in the year 2024.
- Branded is the Fastest growing segment in South Korea Migraine Treatment Market to 2032 with a Growth rate of 23.71 % in forecast period 2025-2032.
-
South Korea Migraine Treatment Market to 2032, By End User
- Hospitals is the largest segment in South Korea Migraine Treatment Market to 2032 with a revenue of 80.59 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in South Korea Migraine Treatment Market to 2032 with a Growth rate of 26.49 % in forecast period 2025-2032.
-
South Korea Migraine Treatment Market to 2032, By Distribution Channel
- Hospital Pharmacies is the largest segment in South Korea Migraine Treatment Market to 2032 with a revenue of 66.84 USD Billion in the year 2024.
- Online Pharmacies is the Fastest growing segment in South Korea Migraine Treatment Market to 2032 with a Growth rate of 24.58 % in forecast period 2025-2032.
South Korea Migraine Treatment Market Company Share Analysis
| Company Name |
|
||
| Novartis AG | |||
| Lilly | |||
| Teva Pharmaceuticals USA, Inc. | |||
| Bayer AG | |||
| Amgen Inc. | |||
South Korea Migraine Treatment Market Geographical Sales Distribution, 2018-2032 USD Billion
South Korea Migraine Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Migraine Treatment Market is segmented based on Segmentation Treatment,Types of Migraine,Product Type,Route of Administration,Type,End User,Distribution Channel.
South Korea Migraine Treatment Market was valued at USD 139.80(Revenue in USD Billion) in 2019.
South Korea Migraine Treatment Market is projected to grow at a CAGR of 24.99% during the forecast period of 2024 to 2032.
The Oral segment is expected to dominate the South Korea Migraine Treatment Market, holding a largest market share of 109.42 USD Billion in 2024
South Korea Migraine Treatment Market Scope
South Korea Migraine Treatment Market Segmentation & Scope
Treatment
- Devices
- Non-Pharmacological Therapies
- Preventive/ Prophylactic Treatment
- Acute / Abortive Treatment
Types of Migraine
- Others
- Chronic
- Migraine with Aura
- Episodic
Product Type
- Over The Counter
- Prescription
Route of Administration
- Others
- Nasal Sprays
- Parenteral
- Oral
Type
- Branded
- Generic
End User
- Others
- Homecare
- Clinics
- Hospitals
Distribution Channel
- Others
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
Frequently Asked Questions
The South Korea Migraine Treatment Market is segmented based on Segmentation Treatment,Types of Migraine,Product Type,Route of Administration,Type,End User,Distribution Channel.
South Korea Migraine Treatment Market was valued at USD 139.80(Revenue in USD Billion) in 2019.
South Korea Migraine Treatment Market is projected to grow at a CAGR of 24.99% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Migraine Treatment Market for final year is USD 404.06 (USD Billion).
South Korea Migraine Treatment Market Company Profiling
Frequently Asked Questions
The South Korea Migraine Treatment Market is segmented based on Segmentation Treatment,Types of Migraine,Product Type,Route of Administration,Type,End User,Distribution Channel.
South Korea Migraine Treatment Market was valued at USD 139.80(Revenue in USD Billion) in 2019.
South Korea Migraine Treatment Market is projected to grow at a CAGR of 24.99% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Migraine Treatment Market for final year is USD 404.06 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.